Nuveen Asset Management, LLC Age X Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$0.68 - $1.13 $41,642 - $69,200
-61,239 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$0.78 - $1.95 $1,742 - $4,356
-2,234 Reduced 3.52%
61,239 $56,000
Q3 2019

Nov 14, 2019
BUY
$1.96 - $3.38 $21,571 - $37,200
11,006 Added 20.98%
63,473 $124,000
Q2 2019

Aug 15, 2019
BUY
$2.58 - $4.92 $135,364 - $258,137
52,467 New
52,467 $192,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email